Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) CEO Lisa Utzschneider sold 14,904 shares of the business's stock in a transaction on Tuesday, July 8th. The shares were sold at an average price of $8.31, for a total transaction of $123,852.24. Following the completion of the sale, the chief executive officer owned 379,316 shares in the company, valued at $3,152,115.96. This represents a 3.78% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Lisa Utzschneider also recently made the following trade(s):
- On Wednesday, May 7th, Lisa Utzschneider sold 8,367 shares of Integral Ad Science stock. The stock was sold at an average price of $7.37, for a total transaction of $61,664.79.
Integral Ad Science Trading Down 4.7%
NASDAQ IAS traded down $0.39 during trading hours on Friday, hitting $7.84. The company's stock had a trading volume of 693,569 shares, compared to its average volume of 966,423. The stock has a fifty day moving average of $8.07 and a 200 day moving average of $8.79. Integral Ad Science Holding Corp. has a twelve month low of $6.26 and a twelve month high of $13.62. The firm has a market capitalization of $1.29 billion, a P/E ratio of 27.03, a PEG ratio of 1.34 and a beta of 1.57. The company has a quick ratio of 4.01, a current ratio of 4.01 and a debt-to-equity ratio of 0.01.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.03 by $0.02. The company had revenue of $134.07 million during the quarter, compared to analysts' expectations of $129.20 million. Integral Ad Science had a return on equity of 4.74% and a net margin of 8.56%. Equities research analysts forecast that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current fiscal year.
Analyst Ratings Changes
IAS has been the topic of several research reports. Robert W. Baird reiterated a "neutral" rating and set a $9.00 price target (down previously from $16.00) on shares of Integral Ad Science in a research report on Friday, March 28th. Raymond James Financial upped their price target on shares of Integral Ad Science from $11.00 to $13.00 and gave the stock an "outperform" rating in a research report on Tuesday, May 13th. Morgan Stanley lowered their target price on Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research note on Thursday, April 17th. Stifel Nicolaus lowered their target price on Integral Ad Science from $15.00 to $13.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Finally, Barclays lifted their target price on Integral Ad Science from $7.00 to $9.00 and gave the company an "equal weight" rating in a research note on Tuesday, May 13th. Six research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $13.55.
Check Out Our Latest Analysis on Integral Ad Science
Institutional Trading of Integral Ad Science
Institutional investors and hedge funds have recently modified their holdings of the stock. DekaBank Deutsche Girozentrale bought a new stake in shares of Integral Ad Science in the 1st quarter valued at about $42,000. State of Wyoming bought a new stake in shares of Integral Ad Science in the 4th quarter valued at about $51,000. Alta Fox Capital Management LLC bought a new stake in shares of Integral Ad Science in the 4th quarter valued at about $61,000. Virtu Financial LLC bought a new stake in shares of Integral Ad Science in the 1st quarter valued at about $87,000. Finally, AlphaQuest LLC bought a new stake in shares of Integral Ad Science in the 1st quarter valued at about $93,000. 95.78% of the stock is owned by institutional investors.
About Integral Ad Science
(
Get Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Featured Stories
Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
